Leo Polz


Leo Polz is partner and co-chair of HOFFMANN EITLE’s biotechnology group.

Dr Polz studied chemistry at the Ludwig Maximilian University of Munich, graduating in 1985, and completed his doctoral thesis in biochemistry in 1989. Until 1990 he conducted research in pharmaceutical biology at Chiba University and Kyoto University, where he was engaged in an investigation on pharmaceutically active compounds from plant cell cultures, elucidation of the structure and biosynthetic routes of secondary metabolites from plants.

Dr Polz joined HOFFMANN EITLE in 1990, qualifying as a German and European patent attorney in 1994.

Dr Polz has a particular focus on patent litigation, opposition and appeal proceedings before the EPO and German Patent Office, the German infringement courts and the German Federal Patents Court. Further, he is active in patent prosecution, legal opinions and due-diligence work. He has particular expertise in the fields of biochemistry and biotechnology, pharmacology and organic chemistry. Dr Polz has experience in litigation involving therapeutically valuable proteins and biologics, such as blood factors, vaccines, hormones (eg, gonadotrophins), mono and multispecific antibodies (eg, adalimumab, eculizumab, trastuzumab, and emicizumab), cell cultures, the polymerase chain reaction, CRISPR and screening methods.

Dr Polz is bilingual in German and English and is learning Chinese. He frequently travels to the United States, Japan and China and has a strong client base in Asia.

Professional associations

  • epi
  • Patent Attorney Bar

Firm details

Arabellastrasse 30
Munich 81925

Contact details

See firm profile